The FDA defied its own experts to approve a new prescription narcotic in a form almost certain to cause addiction and death from overdoses.
On October 26 the savvy investor’s website SeekingAlpha.com published the following remarkable comment about a new and highly addictive painkiller called Zohydro ER, which only the previous day had been approved for sale by the U.S. Food and Drug Administration despite consistent warnings – including from the FDA’s official advisory panel – that Z is potentially more addictive and dangerous than its sister opiate drug, the original and deadly OxyContin.
The full article can be read here:
Latest posts by Jeffrey Lynne (see all)
- DCF Rebukes Florida Legislature on Community Housing Sober Living - August 23, 2018
- FDA Push for MAT Means More Money for Big Pharma - August 8, 2018
- California Challenges HealthNet for Failing to Pay Addiction Treatment Programs - August 6, 2018